The Technical AnalystExchange: HEL Sector: Healthcare Industry: Medical Devices
Revenio Group Oyj Price, Forecast, Insider, Ratings, Fundamentals & Signals
-1.53% €25.80
America/New_York / 2 mai 2024 @ 11:29
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 686.09 mill |
| EPS: | 0.690 |
| P/E: | 37.39 |
| Earnings Date: | Apr 25, 2024 |
| SharesOutstanding: | 26.59 mill |
| Avg Daily Volume: | 0.0259 mill |
| RATING 2024-05-02 |
|---|
| S- |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Neutral | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 2.69x |
| Company: PE 37.39 | sector: PE 13.91 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.93x |
| Company: PE 37.39 | industry: PE 40.39 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
€20.45 (-20.72%) €-5.35 |
| Date: 2024-05-02 |
| Expected Trading Range (DAY) |
|---|
|
€ 25.02 - 26.58 ( +/- 3.01%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | €25.80 (-1.53% ) |
| Volume | 0.0124 mill |
| Avg. Vol. | 0.0259 mill |
| % of Avg. Vol | 47.86 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For REG1V.HE
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
REG1V.HE
Revenio Group Oyj, a health technology company, designs, manufactures, and sells ophthalmic diagnostics and devices for the detection of glaucoma, macular degeneration, diabetic retinopathy, and cataracts in Finland, rest of Europe, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging; DRSplus, a device for detection of diabetic retinopathy; iCare MAIA, a microperimeter to measure the visual field; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. It also provides Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.